antigen presenting cell; article; coronavirus disease 2019; drug delivery system; drug formulation; drug industry; dry powder; human; immune response; immunogenicity; inhalation; liquid; mass immunization; mucosal immunity; needlestick injury; physical chemistry; powder; risk reduction; vaccination; virus replication; SARS-CoV-2 vaccine/ih [Inhalational Drug Administration]